Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2012-005359-18-IT
EUCTR2012-005359-18-IT
Active, not recruiting
Not Applicable

Heart Rate reduction by IVabradine for improvement of ENDothELial function in patients with coronary artery disease: the RIVENDEL study - RIVENDE

IVERSITA' CAMPUS BIOMEDICO0 sitesDecember 21, 2012
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
DrugsCORLENTOR*14CPR RIV 5MG ALL/PV

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
IVERSITA' CAMPUS BIOMEDICO
Status
Active, not recruiting
Last Updated
12 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 21, 2012
End Date
TBD
Last Updated
12 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
IVERSITA' CAMPUS BIOMEDICO

Eligibility Criteria

Inclusion Criteria

  • •ISCHEMIC HEART DISEASE PATIENTS TREATED WITH CORONARY ANGIOPLASTY AND ON TOP OF MEDICAL TREATMENT
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range: 0
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range 30
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range 70

Exclusion Criteria

  • •Patients with resting heart rate \<60 bpm.
  • •Patients undergoing revascularization for STEMI.
  • •Patients with severe left ventricular dysfunction (ejection fraction \= 35%).
  • •Patients with chronic renal failure, severe (GFR \<60 ml / min).
  • •Patients with liver disease.
  • •Patients with atrial fibrillation and atrial flutter.
  • •Patients with pacemakers.
  • •Patients with disease of the sinoatrial node, sinoatrial block, long QT syndrome, complete AV block.
  • •Patients with chronic inflammatory disease and cancer.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Trial of ivabradine for controlling high heart rate control in septic shock.Health Condition 1: null- Septic shock
CTRI/2017/09/009849All India Institute of Medical Sciences New Delhi60
Not yet recruiting
Not Applicable
Role of Ivabradine in reducing tachycardia induced adverse outcomes in severe septic shockHealth Condition 1: O- Medical and Surgical
CTRI/2022/01/039557Calcutta national medical college
Completed
Phase 4
Ivabradine to Improve Endothelial Function in Patients With Coronary Artery DiseaseCoronary Artery Disease
NCT02681978Campus Bio-Medico University70
Active, not recruiting
Not Applicable
Senkung einer erhöhten Herzfrequenz durch Ivabradin bei Patienten mit Multiorgandysfunktionssyndrom. - MODIfYPatienten mit MODS (Multiorgandysfunktionssyndrom)
EUCTR2009-015499-88-DEMartin-Luther-Universität Halle-Wittenberg
Completed
Not Applicable
Effect of cardiac drug ivabradine on heart rate and blood pressure stability in patients undergoing off pump Coronary Artery Bypass surgery.Health Condition 1: null- patients with coronary artery disease who have to undergo coronary artery bypass grafting under general anaesthesia
CTRI/2015/06/005858G B Pant Hospital50